N. Freymond

1.2k total citations
45 papers, 576 citations indexed

About

N. Freymond is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, N. Freymond has authored 45 papers receiving a total of 576 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 15 papers in Physiology and 10 papers in Epidemiology. Recurrent topics in N. Freymond's work include Asthma and respiratory diseases (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers) and Respiratory Support and Mechanisms (5 papers). N. Freymond is often cited by papers focused on Asthma and respiratory diseases (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers) and Respiratory Support and Mechanisms (5 papers). N. Freymond collaborates with scholars based in France, India and United States. N. Freymond's co-authors include Yves Pachéco, Benoît Guibert, Gilles Devouassoux, Serge Lebecque, Sylvie Isaac, Ivan Perrot, Dominique Blanchard, Y. Pachéco, Jean‐François Nicolas and Éric Van Ganse and has published in prestigious journals such as The Journal of Immunology, Current Biology and European Respiratory Journal.

In The Last Decade

N. Freymond

40 papers receiving 556 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Freymond France 11 226 177 155 135 88 45 576
Norihiro Kaneko Japan 12 82 0.4× 256 1.4× 169 1.1× 188 1.4× 210 2.4× 57 698
D Donati Italy 12 76 0.3× 89 0.5× 127 0.8× 129 1.0× 105 1.2× 25 599
Jens Helby Denmark 9 70 0.3× 66 0.4× 70 0.5× 124 0.9× 103 1.2× 21 425
P Errasti Spain 14 113 0.5× 107 0.6× 61 0.4× 41 0.3× 58 0.7× 54 614
M C Liu China 9 127 0.6× 331 1.9× 33 0.2× 442 3.3× 77 0.9× 13 696
Deyun Cheng China 13 80 0.4× 232 1.3× 41 0.3× 144 1.1× 48 0.5× 33 437
Jin Woo Kim South Korea 16 60 0.3× 368 2.1× 126 0.8× 138 1.0× 90 1.0× 38 608
Sandra D. MacDonald United States 8 57 0.3× 567 3.2× 107 0.7× 220 1.6× 69 0.8× 11 790
Hiromasa Harada Japan 12 109 0.5× 152 0.9× 64 0.4× 45 0.3× 85 1.0× 20 438
Barbara Dierdorp Netherlands 9 167 0.7× 111 0.6× 23 0.1× 223 1.7× 65 0.7× 15 422

Countries citing papers authored by N. Freymond

Since Specialization
Citations

This map shows the geographic impact of N. Freymond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Freymond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Freymond more than expected).

Fields of papers citing papers by N. Freymond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Freymond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Freymond. The network helps show where N. Freymond may publish in the future.

Co-authorship network of co-authors of N. Freymond

This figure shows the co-authorship network connecting the top 25 collaborators of N. Freymond. A scholar is included among the top collaborators of N. Freymond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Freymond. N. Freymond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Freymond, N., et al.. (2025). Rank and social context influence sleep in wild chimpanzees. Current Biology. 36(1). 199–208.e4.
2.
Freymond, N., Gilles Boschetti, Fanny Lebossé, et al.. (2024). Evolving Practices in Immune-Related Adverse Event Management: Insights From the IMMUCARE Multidisciplinary Board. JCO Oncology Practice. 21(3). 342–350. 3 indexed citations
3.
Devouassoux, Gilles & N. Freymond. (2024). Bronchopneumopathie chronique obstructive. Revue des Maladies Respiratoires Actualités. 60(4). 559–65.
4.
Freymond, N., Florent Wallet, Thomas Gilbert, et al.. (2023). High flow nasal oxygen in frail COVID-19 patients hospitalized in intermediate care units and non-eligible to invasive mechanical ventilation. Respiratory Medicine and Research. 84. 101026–101026. 1 indexed citations
5.
Pachéco, Yves, Dominique Valeyre, Thomas El Jammal, et al.. (2021). Autophagy and Mitophagy-Related Pathways at the Crossroads of Genetic Pathways Involved in Familial Sarcoidosis and Host-Pathogen Interactions Induced by Coronaviruses. Cells. 10(8). 1995–1995. 10 indexed citations
6.
Freymond, N., F. Gormand, G. Chatté, et al.. (2019). Benefit of continuous positive airway pressure on work quality in patients with severe obstructive sleep apnea. Sleep And Breathing. 23(3). 753–759. 5 indexed citations
7.
Provoost, Judith, Florent Valour, D. Gamondès, et al.. (2018). A retrospective study of factors associated with treatment decision for nontuberculous mycobacterial lung disease in adults without altered systemic immunity. BMC Infectious Diseases. 18(1). 659–659. 13 indexed citations
8.
Grard, S., et al.. (2017). Un cas atypique de pneumopathie nécrosante staphylococcique !. Revue des Maladies Respiratoires. 34(9). 1007–1010. 1 indexed citations
9.
Pachéco, Yves, Alain Calender, Dominique Israël‐Biet, et al.. (2016). Familial vs. sporadic sarcoidosis: BTNL2 polymorphisms, clinical presentations, and outcomes in a French cohort. Orphanet Journal of Rare Diseases. 11(1). 165–165. 18 indexed citations
10.
Catho, Gaud, S. Couraud, S. Grard, et al.. (2015). Management of emerging multidrug-resistant tuberculosis in a low-prevalence setting. Clinical Microbiology and Infection. 21(5). 472.e7–472.e10. 4 indexed citations
11.
Avrillon, Virginie, M. Locatelli-Sanchez, Laure Folliet, et al.. (2015). Lung Cancer May Increase Serum Procalcitonin Level. Infectious Disorders - Drug Targets. 15(1). 57–63. 33 indexed citations
12.
Cordier, Jean-François, Vincent Cottin, C. Khouatra, et al.. (2012). Hypereosinophilic obliterative bronchiolitis: a distinct, unrecognised syndrome. European Respiratory Journal. 41(5). 1126–1134. 25 indexed citations
13.
Freymond, N., et al.. (2011). Clonal expansion of T cells in patients with eosinophilic lung disease. Allergy. 66(11). 1506–1508. 7 indexed citations
14.
Giraud, Sophie, et al.. (2011). Pneumothorax itératifs et spontanés révélant un syndrome de Birt-Hogg-Dubé. Revue des Maladies Respiratoires. 28(3). 355–359. 2 indexed citations
15.
Laforest, Laurent, François Denis, Éric Van Ganse, et al.. (2010). Correlates of adherence to respiratory drugs in COPD patients. Primary Care Respiratory Journal. 19(2). 148–154. 43 indexed citations
16.
Freymond, N., Christophe Malcus, Yves Pachéco, & Gilles Devouassoux. (2009). Lymphocytopenia-associated sarcoidosis: CD4+ T-cell hypo-responsiveness to IL-2 and lectin. Respiratory Medicine CME. 3(2). 113–115. 2 indexed citations
17.
Ngahane, Bertrand Hugo Mbatchou, Alexandra Traverse‐Glehen, N. Freymond, et al.. (2009). Évaluation des facteurs pronostiques du synovialosarcome thoracique. Revue des Maladies Respiratoires. 27(1). 93–97. 5 indexed citations
18.
Devouassoux, Gilles, Alexandre Pachot, Laurent Laforest, et al.. (2007). Galectin‐10 mRNA is overexpressed in peripheral blood of aspirin‐induced asthma. Allergy. 63(1). 125–131. 37 indexed citations
19.
Philit, F., et al.. (2006). Devenir des patients BPCO traités par ventilation non invasive prolongée à domicile. Revue des Maladies Respiratoires. 23(5). 438–444. 2 indexed citations
20.
Freymond, N., et al.. (2003). Skin delayed‐type hypersensitivity to josamycin. Allergy. 58(12). 1319–1320. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Norihiro Kaneko Breakdown of academic impact, for papers by D Donati Breakdown of academic impact, for papers by Jens Helby Breakdown of academic impact, for papers by P Errasti Breakdown of academic impact, for papers by M C Liu Breakdown of academic impact, for papers by Deyun Cheng Breakdown of academic impact, for papers by Jin Woo Kim Breakdown of academic impact, for papers by Sandra D. MacDonald Breakdown of academic impact, for papers by Hiromasa Harada Breakdown of academic impact, for papers by Barbara Dierdorp
Rankless by CCL
2026